-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Medpace Holdings, Raises Price Target to $624

Benzinga·07/24/2026 11:34:46
Listen to the news
Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $547 to $624.